Quadrant Private Wealth Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Quadrant Private Wealth Management's GILD Position: Q2 2026 in Review
Quadrant Private Wealth Management sold out of Gilead Sciences (GILD) in Q2 2026, closing a stake of 2,802 shares — an estimated $391K sold.
Quadrant Private Wealth Management first reported a position in GILD in Q1 2020 and held it in 21 quarters. The position peaked at $1.06M in Q2 2020. 2,278 funds tracked by Wall St. Rank hold GILD as of Q2 2026.
- Quadrant Private Wealth Management reported no remaining Gilead Sciences position as of Q2 2026 after selling out during the quarter.
- Quadrant Private Wealth Management sold 2,802 Gilead Sciences shares in Q2 2026, an estimated $391K.
- Quadrant Private Wealth Management first reported a position in Gilead Sciences in Q1 2020 and held it in 21 quarters.
- Quadrant Private Wealth Management's Gilead Sciences position peaked at $1.06M in Q2 2020.
- 2,278 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.
Based on Quadrant Private Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.